While Cabaletta Bio Inc has underperformed by -5.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CABA fell by -68.03%, with highs and lows ranging from $26.35 to $3.47, whereas the simple moving average fell by -64.74% in the last 200 days.
On October 10, 2024, UBS started tracking Cabaletta Bio Inc (NASDAQ: CABA) recommending Buy. A report published by Jefferies on February 05, 2024, Initiated its previous ‘Buy’ rating for CABA. William Blair also rated CABA shares as ‘Outperform’, setting a target price of $38 on the company’s shares in an initiating report dated November 29, 2023. Cantor Fitzgerald Initiated an Overweight rating on October 24, 2023, and assigned a price target of $40. Stifel initiated its ‘Buy’ rating for CABA, as published in its report on October 19, 2023. Citigroup’s report from September 05, 2023 suggests a price prediction of $22 for CABA shares, giving the stock a ‘Buy’ rating. Guggenheim also rated the stock as ‘Buy’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Cabaletta Bio Inc (CABA)
In order to gain a clear picture of Cabaletta Bio Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -48.16% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.52, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.02M can be a very valuable indicator of volatility for CABA stock. On a monthly basis, the volatility of the stock is set at 9.09%, whereas on a weekly basis, it is put at 9.52%, with a loss of -0.92% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.90, showing growth from the present price of $4.29, which can serve as yet another indication of whether CABA is worth investing in or should be passed over.
How Do You Analyze Cabaletta Bio Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 15.78%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.01% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CABA shares are owned by institutional investors to the tune of 95.01% at present.
